signaling was not blocked by inhibitors of purinergic receptors, ryanodine receptors, or voltage-dependent Ca 2ϩ channels, suggesting a role for IP 3, rather than Ca 2ϩ , in VSM-to-endothelium communication. Block of intermediate-conductance Ca 2ϩ -sensitive K ϩ channels, which have been shown to colocalize with IP3 receptors in endothelial projections to VSM, enhanced nerve-evoked constriction. Collectively, our results support the concept of a transcellular negative feedback module whereby sympathetic nerve stimulation elevates EC Ca 2ϩ signals to oppose vasoconstriction. calcium signaling; myoendothelial junction; inositol 1,4,5-trisphosphate receptors; endothelium; vascular smooth muscle; endothelial cells SYMPATHETIC NERVES regulate vascular tone through the corelease of ATP and norepinephrine (NE) at neurovascular junctions (41) . NE acts on vascular smooth muscle (VSM) cell (VSMC) G q -coupled ␣ 1 -adrenergic receptors [the predominant ␣-adrenergic receptor isoform in mesenteric VSM (21, 43) ] to activate phospholipase C (PLC) and elevate diacylglycerol and inositol 1,4,5-trisphosphate (IP 3 ), thereby activating PKC and IP 3 receptors (IP 3 Rs) in the sarcoplasmic reticulum. ATP released at sympathetic nerve-muscle junctions activates VSMC ionotropic purinergic P2X receptors, specifically P2X 1 receptors (P2X 1 Rs), and causes an influx of extracellular Ca 2ϩ and Na ϩ into the cell, creating an excitatory junction potential that, if sufficiently large, activates voltage-dependent Ca 2ϩ channels (VDCCs) and promotes contraction (23, 33, 46) . Activation of purinergic and adrenergic receptors induces two temporally distinct Ca 2ϩ events in VSMCs: fast, rapidonset junctional Ca 2ϩ transients and slower-onset Ca 2ϩ waves (23, 24) . Junctional Ca 2ϩ transients reflect P2X 1 R-mediated Ca 2ϩ influx (11, 24, 25) , whereas Ca 2ϩ waves are propagating elevations in Ca 2ϩ caused primarily by IP 3 -mediated Ca 2ϩ release from the sarcoplasmic reticulum (10, 12, 15, 18, 45) that may also contribute to VSM contraction (31, 46) . In addition to perivascular sympathetic nerves, luminal endothelial cells (ECs) also modulate VSMC function through the production of vasodilators such as nitric oxide (NO) and through EDHF (6, 32) . However, more recent evidence has suggested that the converse pathway, signaling from VSMCs to ECs, may be important for the regulation of arterial diameter in response to stimuli, such as KCl and phenylephrine (PE), that cause VSMC contraction (4) . This observation is consistent with previous reports (4, 14, 37, 42) showing that adrenergic receptor activation by exogenous agonists not only elevates intracellular Ca 2ϩ in VSMCs but also increases Ca 2ϩ in the ECs lining these vessels. A previous report (16) has described spontaneous local EC Ca 2ϩ events in rat mesenteric arteries after the stimulation of VSM with PE, without further defining the location of these Ca 2ϩ events. The current thinking is that this VSM-to-endothelium signal is communicated via the passage of a factor (e.g., Ca 2ϩ or IP 3 ) through myoendothelial gap junctions, which connect VSMCs to endothelial projections through the internal elastic lamina, to elevate EC Ca 2ϩ (4, 16, 22 (27, 39) , which express the Ca 2ϩ biosensor GCaMP2 specifically in ECs, our laboratory has recently identified and characterized IP 3 -mediated Ca 2ϩ -release events, termed Ca 2ϩ pulsars, within endothelial projections of mesenteric arteries to smooth muscle, establishing this approach as a powerful tool for monitoring EC Ca 2ϩ signaling at or near the connection points to smooth muscle.
In this study, we tested the hypothesis that brief sympathetic nerve stimulation can engage the vascular endothelium to oppose vasoconstriction. To accomplish this, we determined the effects of sympathetic nerve stimulation on EC Ca 2ϩ signaling in intact mesenteric arteries using the GCaMP2 mouse model. Our results are consistent with a model in which NE released from sympathetic nerves activates VSMC ␣ 1 -adrenergic receptors to engage EC IP 3 Rs in myoendothelial projections and subsequently activate EC IK channels to oppose vasoconstriction.
EXPERIMENTAL PROCEDURES
Mouse models and tissue preparations. All procedures were approved by the Institutional Animal Care and Use Committee of the University of Vermont. Wild-type C57BL/6 and transgenic Cx40
Bac -GCaMP2 mice were used. The Cx40 BacGCaMP2 mouse expresses the Ca 2ϩ biosensor GCaMP2 under the control of the Cx40 promoter and thus expresses GCaMP2 only in ECs in the vasculature (27, 39 Electrical field stimulation. Two platinum electrodes (0.25-mm diameter, World Precision Instruments) were placed in parallel on either side of a mesenteric artery (or en face preparation) and connected to a Grass S48 stimulator. After equilibration at 35°C, perivascular nerves of pressurized (80 mmHg) arteries or en face arterial preparations were stimulated by trains of electrical pulses (50 -150 V, 0.25-ms pulse, 15 Hz, 5-s train duration). A submaximal voltage was used and was varied initially to some extent until a stable response was achieved. The voltage remained constant throughout both imaging experiments and diameter measurements. The train duration was 5 s to minimize tissue movement for Ca 2ϩ measurements in the en face preparation (9, 25) .
Diameter measurements of isolated mesenteric arteries. Arteries were cannulated to size-matched micropipettes on an arteriograph system, pressurized to 80 mmHg using an electronic servo-pressure transducer (Living Systems Instrumentation, Burlington, VT), and continuously perfused with oxygenated, prewarmed (37°C) physiological saline solution. All ion channel blockers were added to the bath solution. Luminal vessel diameter was monitored using a charge-coupled device camera and edge-detection software (IonOptix). Electrical field stimulation (EFS)-evoked constrictions were analyzed using MiniAnalysis (Synaptosoft, Fort Lee, NJ) software. EFSevoked constrictions were measured as the area under the curve (AUC) and calculated for the region between the baseline and maximum constriction from the point of EFS application to 95% recovery of the diameter to pre-EFS values. Both fast and slow decay phases of constriction were included in the calculations of AUC and thereby provide an index of overall constrictor responses. At least three constrictions per artery were averaged. Ca 2ϩ imaging. Ca 2ϩ imaging was performed on third-order mesenteric artery en face preparations using an Andor Technology Nipkow spinning-disk confocal system coupled to a Nikon Eclipse E600 FN upright microscope with a ϫ60 waterdipping objective (numerical aperture: 1.0); images were acquired at 15-30 images/s. Cx40
Bac -GCaMP2 mice were used to detect pulsars, which are local, stationary, IP 3 R-mediated events (27) . Pulsar area, measured at 50% peak amplitude, was found to be ϳ14 m 2 , as previously observed (27) . GCaMP2 was excited at 488 nm with a solid-state laser, and fluorescence emission was collected using a 527.5/49-nm band-pass filter. Ca 2ϩ pulsars were measured offline by detecting an increase in the fractional fluorescence (F/F o ) that was significantly above background noise (F/F o Ͼ 1.2) using custom-designed software. F/F 0 was evaluated in 9 ϫ 9-pixel regions of interest in the collected image positioned at points corresponding to peak pulsar amplitude; F 0 was obtained from the same region of interest in 10 images without activity. The kinetic properties of pulsars were analyzed using our custom software, which was written by A. D. Bonev (27) , and pulsar frequency was determined as number of pulsar events over time per field of view. All events that occurred during EFS, including those that occurred during tissue movement, are presented in histograms. Because some images exhibited movement during EFS, for the sake of consistency, all events that occurred during the 5-s stimulation were excluded in the statistical analysis shown in Fig. 2 , which compares the 20-s time bracket after EFS (starting at the end of the EFS pulse) to the 20-s time bracket before EFS for each pharmacological intervention.
Picospritzing. ATP or PE was directly applied to the endothelial surface of an en face mesenteric artery preparation by picospritzing for 5 s at a pressure of 0.3 bar. Stimulation/ involvement of VSM signaling mechanisms was avoided by adjusting the picospritzer to a distance of ϳ10 m above the endothelium.
Data analysis and statistics. Prism (GraphPad Software, La Jolla, CA) and OriginPro7.5 software were used for statistical tests and preparation of graphs. Data are expressed as means Ϯ SE unless otherwise noted. For Fig. 1 , F and G, means Ϯ SE were calculated using the descriptive "statistics on rows" tool in OriginPro 7.5. For Figs. 2-4, two-tailed paired t-tests were used for the comparison of paired experiments, and two-way repeated-measures ANOVAs followed by Bonferroni post tests were used for the comparison of two or more groups, as appropriate. One-sample t-tests were used to compare a single sample to a hypothetical value. P values of Ͻ0.05 were considered statistically significant. Each experimental treatment condition was performed at least three times on at least three separate animals. Two-sample independent t-tests were applied to compare biophysical characteristics (amplitude, duration, and decay and rise times) of pulsars at existing sites before nerve stimulation to those at newly recruited sites after nerve stimulation.
RESULTS

Stimulation of sympathetic nerves acts through VSM ␣-adrenergic receptors to promote Ca
2ϩ signaling in ECs. Intracellular Ca 2ϩ was measured in ECs in third-order mesenteric arteries from Cx40 Bac -GCaMP2 mice, which express the genetically encoded Ca 2ϩ biosensor GCaMP2 specifically in the vascular endothelium (27, 39) . En face preparations were used in these experiments; the field of view was ϳ120 ϫ 136 m and contained ϳ14 ECs. Inhibitors of muscarinic receptors, purinergic P2Y receptors, and sensory nerves were included in the bath solution (see EXPERIMENTAL PROCEDURES).
In the absence of nerve stimulation, mesenteric artery ECs exhibited a basal level of IP 3 (Figs. 1, A-F, and 2A) . EC pulsar frequency increased within 2-5 s after the start of the stimulation pulse and returned to basal levels ϳ40 s after the cessation of nerve stimulation (Fig. 1F) , consistent with the time course of smooth muscle Ca 2ϩ signaling observed in third-order mesenteric arteries after EFS (23) . Approximately 81% percent of pulsars were located in the vicinity (Ͻ2.5 m) of holes in the internal elastic lamina.
The transient increase in EC Ca 2ϩ -signaling responses to EFS was prevented by TTX (1 M, 5-min incubation), a blocker of neuronal Na ϩ channels (Figs. 1G and 2A). Stimulation of sympathetic nerves leads to the release of NE and ATP, which activate ␣ 1 -adrenergic and P2X 1 Rs, respectively, in VSMCs (41) . Prazosin, an inhibitor of ␣ 1 -adrenergic receptors, prevented the EFS-induced increase in EC Ca 2ϩ signaling (Fig. 2, A and B) . In contrast, the P2X 1 R agonist/antagonist ␣␤-meATP (10 M), which transiently activates and then chronically desensitizes P2X 1 Rs, had no effect on EFS-induced increases in EC Ca 2ϩ signaling ( Fig. 2A) . These results are consistent with the idea that the activation of VSMC ␣ 1 -adrenergic receptors by nerve-released NE leads to an increase in EC Ca 2ϩ signaling. It is nonetheless conceivable that NE and ATP released by sympathetic nerves might directly affect EC Ca 2ϩ signaling. To test this, we directly picospritzed ATP (10 M) or PE (100 M) onto the endothelium of an en face arterial preparation and measured changes in EC Ca 2ϩ signals (Fig. 2C ). PE did not affect EC Ca 2ϩ signaling when picospritzed onto the endothelium, suggesting that the third-order mesenteric artery ECs used in this study do not express the molecular machinery necessary to respond directly to NE, a result consistent with a previous report (14) . However, picospritzed ATP did cause a significant elevation in EC Ca 2ϩ signaling, an effect that was blocked by preincubation with the P2Y 1 receptor antagonist MRS-2179 (3 M, 10-min incubation; Fig. 2C ). Thus, because MRS-2179 is routinely included in all bath solutions (see EXPERIMENTAL PROCEDURES) (44) and ECs are unresponsive to PE, it is unlikely that neurally derived NE or ATP acts directly on the vascular endothelium under the experimental conditions used.
Recent studies (17, 22) have indicated that VSM can communicate with the endothelium through myoendothelial gap junctions in an IP 3 -dependent manner. To explore this possibility, we tested the effects of U-73122 (10 M), an inhibitor of PLC. Inhibition of PLC greatly reduced basal Ca 2ϩ pulsar activity, as previously reported (27) (see also Fig. 2D ), and EFS had no effect.
The lack of effect of P2X 1 R inhibition on EFS-induced EC Ca 2ϩ signaling suggests that P2X 1 R-mediated Ca 2ϩ influx and activation of VDCCs by excitatory junction potentials are not required for EFS-induced EC Ca 2ϩ signaling, further suggesting that VSMC intracellular Ca 2ϩ is not the primary mediator of VSM-to-endothelium signaling. To further explore this issue, we tested the effects of antagonists of VDCCs and ryanodine receptors (RyRs) on nerve-induced increases in EC Ca 2ϩ signaling. Pretreatment with the VDCC blocker nifedipine (5 M) minimized movement in response to EFS but did not affect the increase in EC Ca 2ϩ pulsar activity induced by sympathetic nerve stimulation (Fig. 2A) . Blebbistatin (50 M), a selective inhibitor of myosin-actin interactions, also minimized contraction without affecting EC Ca 2ϩ -signaling responses to EFS (2.3-fold increase in pulsar frequency after EFS, P Ͻ 0.05, n ϭ 4 arteries). Likewise, the RyR blocker ryanodine (10 M) failed to block the increase in EC Ca 2ϩ pulsar activity induced by the stimulation of sympathetic nerves ( Fig. 2A) . Basal EC Ca 2ϩ signaling was also unaffected by nifedipine, blebbistatin, ryanodine, prazosin, and ␣␤-meATP (Fig. 2D) . Collectively, these results suggest that neither increases in smooth muscle global Ca 2ϩ nor elevated RyR-mediated Ca 2ϩ spark activity makes a major contribution to communicating sympathetic nerve input to the endothelium, implying a potential role for IP 3 in transducing this signal.
Sympathetic nerve stimulation recruits new EC Ca 2ϩ -signaling sites. We (27) have previously shown that the endothelial-dependent vasodilator ACh enhances Ca 2ϩ pulsar activity by inducing new sites and by increasing pulsar frequency at existing sites. Thus, EFS could increase EC Ca 2ϩ signaling by affecting activity at existing sites, by recruiting new sites, or both. Here, we found that EFS considerably increased the number of new pulsar sites, with the transient increase in pulsar activity peaking at 4 sites/field per 4 s after EFS, as measured over 20 s (Fig. 3, A and B) . The amplitude, duration, and rise and decay times of Ca 2ϩ pulsars were not significantly changed Events that occurred during EFS were excluded from this analysis because some images showed excessive movement during EFS. EFS significantly increased pulsar activity compared with unstimulated controls. This increase in EC Ca 2ϩ pulsars was prevented by pretreatment with 1 M TTX (n ϭ 8), 500 nM prazosin/10 M ␣␤-meATP (n ϭ 6), or 500 nM prazosin alone (n ϭ 18), which reduced pulsar frequency to levels that were not significantly different from unstimulated controls. EFS-induced pulsar activity was not significantly changed by treatment with 10 M ␣␤-meATP (n ϭ 10), 10 M ryanodine (n ϭ 6), or 5 M nifedipine (n ϭ 5). ns, Not significant. #P Ͻ 0.01 vs. unstimulated controls; *P Ͻ 0.05, **P Ͻ 0.001, and ***P Ͻ 0.0001 vs. EFS alone. B: representative fluorescence (F/F0) traces illustrating the lack of effect of EFS on Ca 2ϩ pulsar activity in the presence of prazosin (500 nM). C: summary graph depicting the twofold elevation in pulsar frequency induced by picospritzing 10 M ATP directly on endothelial cells (ECs) in an en face arterial preparation (n ϭ 3, *P Ͻ 0.05). ATP had no effect in the presence of 3 M MRS-2179 (n ϭ 3), which was routinely included in bath solutions. Picospritzing 100 M phenylephrine (PE; n ϭ 3) on ECs in an en face preparation did not increase Ca 2ϩ pulsar frequency, indicating that neurally released norepinephrine (NE) does not act directly on the endothelium. D: effects of drug treatments on basal pulsar activity. ␣␤-meATP (10 M) ϩ prazosin (500 nM), TTX (1 M), nifedipine (5 M), ryanodine (10 M), and blebbistatin (50 M) had no significant effects on basal pulsar activity (n ϭ 3-6). Application of 10 M U-73122 significantly reduced basal pulsar activity (n ϭ 3-4; *P Ͻ 0.05).
upon nerve stimulation (Table 1) . Interestingly, in contrast to stimulation with ACh, EFS did not increase the frequency of pulsars at existing sites ( Fig. 3C and Table 1) . Therefore, as shown in Fig. 3D , the increase in frequency is due to the appearance of new sites. The residual number of new sites in the presence of TTX (Fig. 3D) provides a measure of the frequency of spontaneously occurring new sites over the duration of the experiment. The addition of prazosin reduced the number of new sites to basal levels (i.e., that observed in the presence of TTX), indicating that inhibition of ␣ 1 -adrenergic receptors prevented the recruitment of new pulsar sites. ␣␤-meATP did not affect EFS induction of new sites (Fig. 3D) (2, 28, 40) , which are also expressed in ECs. IK channels were blocked using the synthetic inhibitor Tram-34 and the scorpion toxin charybdotoxin (ChTx), which also blocks large-conductance (BK) Ca 2ϩ -sensitive K ϩ channels, but not SK channels, with high affinity (3, 28) . In experiments using ChTx, the potential effects of BK channels, which are expressed in VSMCs but not in normal ECs (8, 20, 26, 34) , were eliminated using the selective blocker paxilline (13, 28, 29) . Elevation of intravascular pressure to 80 mmHg induced myogenic tone, constricting these mesenteric arteries by 22.7 Ϯ 0.8% (n ϭ 34). Block of IK channels with Tram-34 (10 M) or ChTx (100 nM, in the presence of paxilline) caused a small, but significant, constriction when added alone (6.3 Ϯ 0.9% and 4.8 Ϯ 0.6% for Tram-34 and ChTx, respectively, n ϭ 5 arteries; Fig. 4) . Block of IK channels also increased EFS-induced vasoconstriction, measured as an integral of the constriction (AUC; Fig. 4, A and F) , by approximately twofold, but did not significantly change peak amplitude (n ϭ 5 arteries, P Ͼ 0.05). In contrast, application of the SK channel blocker apamin (300 nM) did not cause vasoconstriction (1.4 Ϯ 1.0%, n ϭ 5 arteries) and did not significantly alter nerve-induced vasoconstriction (P Ͼ 0.05, n ϭ 5 arteries; Fig. 4B ). These results suggest that EC IK channels tonically oppose pressure-induced constriction as well as EFS-induced constriction.
In addition to SK/IK channel-dependent EDHF, the endothelium releases the vasoactive factors NO and prostanoids through the action of NO synthase (NOS) and cyclooxygenase (COX), respectively (5, 32) . Block of NOS with N-nitro-L- The Ca 2ϩ pulsar parameters shown are peak amplitude [in fractional fluorescence (F/F0)], rise time (measured as the 10%-to-90% signal interval), duration (measured as 50% peak signal width), and half-time for decay of the signal. Kinetic characteristics of Ca 2ϩ pulsars were calculated from 43 and 96 pulsars recorded in 5 fields over 20-s time courses before and after nerve stimulation, respectively. EFS, electrical field stimulation. "After EFS" refers to Ca 2ϩ pulsars originating from new, EFS-induced pulsar sites.
arginine methyl ester [L-NAME (100 M)] and COX with indomethacin (10 M) did not significantly affect nerve-induced vasoconstriction, suggesting that NOS/COX does not play a significant role in opposing nerve-induced vasoconstriction in these mesenteric arteries (P Ͼ 0.05, n ϭ 5 arteries). Consistent with this interpretation, block of IK channels in the presence of L-NAME (100 M)/indomethacin (10 M) resulted in an increase in nerve-induced vasoconstriction comparable to that observed under control conditions (Fig. 4, C and  F) . This suggests that IK channels regulate nerve-evoked constriction in small mesenteric arteries independent of NOS/ COX activity. To confirm that the VSMC ␣ 1 -adrenergic receptor pathway, as described above (see Fig. 2 ), is functionally linked with IK-dependent attenuation of nerve-evoked constriction, we preincubated pressurized mesenteric arteries with prazosin (500 nM) or the purinergic receptor blocker ␣␤-meATP (10 M) and measured changes in EFS-evoked constrictions in the presence and absence of the IK channel blocker ChTx (100 nM). Prazosin reduced the sustained component of EFS- Fig. 4 . Intermediate-conductance (IK) channels oppose nerve-induced constriction via a mechanism that is dependent on vascular smooth muscle cell ␣-adrenergic receptor activation and independent of nitric oxide synthase/cyclooxygenase. A-E: representative diameter changes in pressurized (80 mmHg, 166 Ϯ 25-m maximal diameter and 129 Ϯ 23-m resting diameter, n ϭ 34 arteries) third-order mesenteric arteries in response to EFS (indicated by arrows). Gray areas indicate area under the curve, which was calculated as an integral of the constriction. A: application of 100 nM charybdotoxin (ChTx) in the presence of 1 M paxilline (Pax) increased constriction to identical nerve stimulation by twofold (n ϭ 6 arteries). B: application of 300 nM apamin did not cause vasoconstriction (1.4 Ϯ 1.0%, n ϭ 5 arteries) and did not significantly alter nerve-induced vasoconstriction (P Ͼ 0.05, n ϭ 5 arteries). This increase in EFS-induced constriction produced by inhibition of IK channels with ChTx was not significantly effected by pretreatment with 100 M N-nitro-L-arginine methyl ester (L-NAME)-10 M indomethacin-1 M Pax (n ϭ 5 arteries; P Ͼ 0.05; C) or 10 M ␣␤-meATP-1 M Pax (n ϭ 5 arteries, P Ͼ 0.05; D) but was abolished by pretreatment with 500 nM prazosin-1 M Pax (n ϭ 5 arteries, *P Ͻ 0.05; E). Although 10 M ␣␤-meATP completely abolished peak constriction in response to EFS, its effects on the area under the curve were minimal. F: summary graph illustrating the changes in luminal diameter upon EFS. For all experiments with ChTx, arteries were first incubated with 1 M Pax to block smooth muscle large-conductance channels. Control corresponds to pretreatment of vessels with the indicated pathway inhibitors (in the presence of Pax).
evoked constrictions, measured as the AUC, by 37.9 Ϯ 2.4% (n ϭ 5 arteries, P Ͻ 0.05). The initial rapid constriction, which did not make a major contribution to the total AUC, was eliminated by ␣␤-meATP (n ϭ 4 arteries; Fig. 4D ), confirming that this transient contraction represents the response to an excitatory junction potential caused by the rapid influx of Na ϩ /Ca 2ϩ through P2X 1 Rs. In arteries pretreated with ␣␤-meATP (in the presence of 1 M paxilline), ChTx induced an increase in vasoconstriction comparable to that observed in the absence of ␣␤-meATP (Fig. 4, D and F) . In contrast, the increase in vasoconstriction due to IK channel block was abolished in the presence of prazosin (500 nM; Fig. 4, E and  F) , indicating that the VSMC ␣ 1 -adrenergic receptor signaling pathway is the primary contributor to the local increase in Ca 2ϩ pulsar events at myoendothelial projections, subsequent activation of proximate IK channels, and regulation of vascular tone.
DISCUSSION
Here, we propose the novel concept that brief stimulation of sympathetic nerves induces an increase in IP 3 -mediated Ca 2ϩ pulsars in the endothelial projections to smooth muscle. Our data support a model in which sympathetic nerve stimulation does not activate EC Ca 2ϩ directly but instead induces heterocellular communication from VSMCs to ECs, leading to increased EC Ca 2ϩ pulsar activity at myoendothelial projections (Fig. 5) . Sympathetic nerve-induced Ca 2ϩ pulsars signal locally to activate EC IK channels, engaging a NOS/COXindependent EDHF mechanism that opposes nerve-induced vasoconstriction. Each of the sympathetic nerve-evoked responses (increased EC Ca 2ϩ pulsar activity, IK channel activation, and regulation of vasoconstriction) is mediated by VSMC ␣ 1 -adrenergic signaling.
Our finding that VSMC ␣-adrenergic receptor activation increases EC Ca 2ϩ signaling is consistent with previous reports (4, 14, 37, 42) showing that VSMC adrenergic receptor activation by bath-applied PE increases Ca 2ϩ in the ECs lining these vessels. Activation of ␣ 1 -adrenergic receptors elevates the levels of both smooth muscle IP 3 (19, 22) have reported that activation of VDCCs has no effect on endothelial Ca 2ϩ . The consensus of recent studies (17, 22, 35) supports the concept that IP 3 is the currency of communication after the stimulation of VSMC adrenergic receptors with PE. Our data reinforce the importance of adrenergic signaling in this mechanism and further define the nature of the EC Ca 2ϩ signal, showing that NE transiently released from sympathetic nerves acts through VSMC ␣ 1 -adrenergic receptor signaling pathways to increase EC Ca 2ϩ pulsar activity. Furthermore, our data suggest that activation of EC IK channels should attenuate the NE-induced smooth muscle membrane potential depolarization.
Previous studies (4, 14, 16, 22, 35, 37) have examined the steady-state effects of continuous PE exposure on endothelial Ca 2ϩ . Here, we examined the effects of nerve stimulation for Fig. 5 . Model of negative feedback regulation by the endothelium in response to sympathetic nerve stimulation. Activation of sympathetic nerves leads to the corelease of ATP and NE, which activate vascular smooth muscle cell purinergic receptors (P2X1Rs) and ␣1-adrenergic receptors [␣1-G protein-coupled receptors (␣1-GPCR)], respectively. The subsequent elevation of smooth muscle inositol 1,4,5-trisphosphate (IP3) by the activation of ␣1-adrenergic receptors is transmitted through myoendothelial gap junctions to IP3 receptors (IP3Rs) in the endothelial projections to increase intracellular Ca 2ϩ (pulsars). This, in turn, activates colocalized EC IK channels, providing a hyperpolarizing influence on the smooth muscle to oppose vasoconstriction. VDCC, voltage-dependent Ca 2ϩ channels; PLC, phospholipase C; SR, sarcoplasmic reticulum; IEL, inner elastic lamina; ER, endoplasmic reticulum. 5 s on EC Ca 2ϩ signaling associated with endothelial projections to smooth muscle. We found that Ca 2ϩ pulsar activity was elevated ϳ3 s after the onset of EFS and remained elevated for ϳ40 s (Fig. 1) . Consistent with the idea that IP 3 derived from stimulated smooth muscle causes a delayed activation of IP 3 -mediated Ca 2ϩ pulsars in endothelial projections, Wier and colleagues (23) found that smooth muscle IP 3 -mediated Ca 2ϩ waves remained elevated for 60 s after the cessation of EFS. Our data on nerve-evoked constrictions are also consistent with this view in that block of IK channels affected the duration, measured as the AUC, but not the initial, purinergic-mediated amplitude (Fig. 4) . Ca 2ϩ pulsars return to baseline within 1 min after stimulation, whereas the constriction lasts longer. This lag presumably reflects the time course of membrane repolarization, reduction in smooth muscle Ca 2ϩ , and ultimately force. Collectively, these findings are in accord with reports suggesting a role for IP 3 rather than Ca 2ϩ in VSM-to-endothelium communication.
The architectural features of endothelial projections through the elastic lamina create a microdomain that forms the basis for the signaling mechanism described here. These endothelial projections are home to evaginations of the endoplasmic reticulum containing IP 3 Rs (the source of Ca 2ϩ pulsars) and make direct contact with VSMCs via myoendothelial gap junctions, which are composed of Cxs (Cx37 and Cx40), that allow the diffusion of small molecules between VSMCs and ECs (7, 30, 36) . Even though endothelial NOS has been shown to colocalize at myoendothelial gap junctions (38) , our data suggest that neither NOS nor COX activity plays a significant role in opposing sympathetic nerve-induced vasoconstriction in thirdorder mesenteric arteries (Fig. 4) . Importantly, IK channels have been shown to localize to the myoendothelial projections (27, 36) , placing them in a position to respond to local elevations of Ca 2ϩ generated by Ca 2ϩ pulsar activity. Our data suggest that EC IK channels tonically oppose pressure-induced, as well as nerve-induced, constrictions in small resistance arteries (Fig. 4) , similar to their regulation of parenchymal arteriolar diameter and cortical cerebral blood flow (8) . Interestingly, the increase in Ca 2ϩ pulsar activity observed upon nerve stimulation reflected the recruitment of new Ca 2ϩ pulsar sites in ECs rather than an increase in the activity of existing sites (Figs. 1 and 3 ). Although our experiments did not address this directly, this outcome is precisely what one would predict if the "goal" was to create a system with maximal gain, assuming that IK channels in the vicinity of existing pulsar sites are at least partially activated under basal conditions. The effect of EFS on pulsars was somewhat different from that of ACh, which predominantly recruited new pulsar sites but also increased the activity of existing sites (27) . This difference could reflect the source of IP 3 generation (endothelium vs. smooth muscle) and the degree to which IP 3 Rs are saturated with IP 3 and Ca 2ϩ . Taken together, our data elucidate a novel signaling mechanism in which the stimulation of sympathetic nerves activates VSMC adrenergic receptors to increase EC Ca 2ϩ pulsar activity in endothelial projections, ultimately activating nearby IK channels to oppose nerve-induced vasoconstriction and regulate sympathetic tone. Thus, the endothelium actively responds to sympathetic nerve stimulation to regulate vessel diameter and sympathetic tone.
